ABSTRACT
Purpose Large-scale genomic studies have significantly increased our knowledge of genetic variability across populations. Regional genetic profiling is essential for distinguishing common benign variants from disease-causing ones. To this end, we conducted a comprehensive characterization of exonic variants in the population of Navarre (Spain).
Methods Genome sequencing data from 358 unrelated individuals of Spanish origin from the Navarrese population were used.
Results Our analysis revealed 61,410 biallelic exonic single nucleotide variants (SNV) within the Navarrese cohort, with 35% classified as common (MAF > 1%). By comparing allele frequency data from 1000 Genome Project (excluding the Iberian cohort of Spain, IBS), Genome Aggregation Database, and a Spanish cohort (including IBS individuals and data from Medical Genome Project), we identified 1,069 SNVs common in Navarre but rare (MAF ≤ 1%) in all other populations. We further corroborated this observation with a second regional cohort of 239 unrelated exomes, which confirmed 676 of the 1,069 SNVs as common in Navarre.
Conclusion This study highlights the importance of population-specific characterization of genetic variation to improve allele frequency filtering in sequencing data analysis to identify disease-causing variants.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
NAGEN1,000 and PharmaNAGEN were supported by Navarra Gov (Direccion General de Industria, Energia y Proyectos Estrategicos S3). GRANTS_NUMBERS: 0011-1411-2017-000032, 0011-1411-2018-000047.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
NAGEN1,000 and PharmaNAGEN were approved by Navarra Ethics Committee for Clinical Research (CEIC Navarra).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
alberto.ruizdeinfante{at}kaust.edu.sa, ehuergoi{at}navarra.es, mv.apellaniz.ruiz{at}navarra.es, eurruDl{at}navarra.es, mmirandp{at}navarra.es, jsalgadg{at}navarra.es, spasalos{at}navarra.es, lunadelde{at}gmail.com, oteijidh{at}navarra.es, igoicoeo{at}naserDc.es, rosariom.carmona{at}juntadeandalucia.es, Error! Hyperlink reference not valid., virginia.aquino{at}juntadeandalucia.es, daniel.lopez.lopez{at}juntadeandalucia.es, maria_pena{at}iislafe.es, sergi.beltran{at}cnag.eu, joaquin.dopazo{at}juntadeandalucia.es, ilasa{at}unavarra.es, jj.beloqui.lizaso{at}navarra.es, aalonsos{at}navarra.es, david.gomez.cabrero{at}navarra.es
Reducing the number of words and adding admixture results.
Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
DATA AVAILABILITY
Data is available from the corresponding author upon reasonable request.
